Ftse Mib
34.683,22
0,55%
DAX
18.608,16
0,68%
S&P 500
5.272,25
-0,10%
NASDAQ
16.808,73
0,44%
Bitcoin
69.324,44
2,33%
Registration Strip Icon for charts Registrati per grafici in tempo reale, strumenti di analisi e prezzi.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Caribou Biosciences Inc (CRBU) Caribou Biosciences Inc (CRBU) Notizie

Caribou Biosciences Inc

CRBU
2,1699
-0,7101 (-24,66%)
Ultimo aggiornamento: 17:37:56
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
03/6/202412:01EDGAR2Form 8-K - Current report
03/6/202401:00GLOBECaribou Biosciences Presents Encouraging Clinical Data from..
30/5/202422:01GLOBECaribou Biosciences to Host KOL Discussion with Webcast from..
07/5/202422:11EDGAR2Form 8-K - Current report
07/5/202422:05GLOBECaribou Biosciences Reports First Quarter 2024 Financial..
01/5/202422:05GLOBECaribou Biosciences to Participate in Upcoming Investor..
24/4/202416:00GLOBECaribou Biosciences to Present Initial Dose Expansion Data..
15/4/202415:00GLOBECaribou Biosciences Announces Oral Presentation on In Vivo..
04/4/202422:00GLOBECaribou Biosciences Expands Clinical Development of CB-010..
11/3/202422:08EDGAR2Form S-8 - Securities to be offered to employees in employee..
11/3/202421:25EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
11/3/202421:22EDGAR2Form 8-K - Current report
11/3/202421:05GLOBECaribou Biosciences Reports Fourth Quarter and Full Year..
05/3/202422:30GLOBECaribou Biosciences to Present Preclinical Data on CB-012,..
22/2/202423:28EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/2/202423:21EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/2/202423:18EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/2/202423:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/2/202423:12EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/2/202423:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/2/202423:08EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/2/202423:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/2/202423:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/2/202422:54EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/2/202422:05GLOBECaribou Biosciences to Participate in Upcoming Investor..
08/2/202423:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/1/202422:18EDGAR2Form 3/A - Initial statement of beneficial ownership of..
09/1/202422:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/1/202422:07EDGAR2Form 3 - Initial statement of beneficial ownership of..
08/1/202422:18EDGAR2Form SC 13G - Statement of acquisition of beneficial..
08/1/202414:00EDGAR2Form 8-K - Current report
07/1/202417:00GLOBECaribou Biosciences Appoints Tim Kelly as Chief Technology..
22/12/202322:05EDGAR2Form 8-K - Current report
13/12/202312:30IHMARKETNEWSCal-Maine Avian Flu Outbreak Impact, Amgen Hikes Dividend..
13/12/202300:26DJNCaribou Biosciences Shares Rise 4.1% as FDA Approves..
12/12/202322:05EDGAR2Form 8-K - Current report
12/12/202322:02GLOBECaribou Biosciences Provides Regulatory Update on CB-010..
17/11/202322:06EDGAR2Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]:..
17/11/202322:05EDGAR2Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]:..
07/11/202322:03EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
07/11/202322:02EDGAR2Form 8-K - Current report
07/11/202322:00GLOBECaribou Biosciences Reports Third Quarter 2023 Financial..
06/11/202314:00GLOBECaribou Biosciences Announces Appointment of Sundar..
01/11/202321:05GLOBECaribou Biosciences to Participate in Upcoming Investor..
18/10/202314:02EDGAR2Form 8-K - Current report
18/10/202314:00GLOBECaribou Biosciences Announces FDA Clearance of IND..
27/9/202314:00GLOBECaribou Biosciences Appoints Reigin Zawadzki as Chief People..
26/9/202322:05EDGAR2Form 8-K - Current report
29/8/202322:00GLOBECaribou Biosciences to Participate in Upcoming Investor..
08/8/202322:06EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Apertura: 1,92 Min: 1,75 Max: 2,30
Chiusura: 2,88

La tua Cronologia

NASDAQ
CRBU
Caribou Biosciences
NASDAQ
ZNDT
Zindart
BIT
P45370
Bnp Paribas Issuance
EU
ALVIO
Valerio Therapeutics
TSX
FSB
CI Enhanced Short Duration
COIN
DEFTEUR
COIN
ECELLEUR
BIT
P1SXG2
BNP Paribas Issuance
BIT
UB9C37
Unicredit Bank
BIT
P1KV45
BNP Paribas Issuance
XE
HXCK
Ernst Russ
LSE
KOO
Kooth
BIT
UC567F
Unicredit Bank
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network